vs
CORCEPT THERAPEUTICS INC（CORT）与PROSPERITY BANCSHARES INC（PB）财务数据对比。点击上方公司名可切换其他公司
PROSPERITY BANCSHARES INC的季度营收约是CORCEPT THERAPEUTICS INC的1.8倍（$367.6M vs $202.1M），PROSPERITY BANCSHARES INC净利率更高（31.6% vs 12.0%，领先19.6%），过去两年PROSPERITY BANCSHARES INC的营收复合增速更高（19.2% vs 17.3%）
Corcept Therapeutics是一家制药企业，专注于严重代谢疾病、精神疾病及肿瘤疾病治疗药物的发现、开发与商业化。公司围绕皮质醇过量带来的不良影响展开研究，致力于开发可缓解相关症状的新型化合物，管理团队由首席执行官兼总裁、董事Joseph K. Belanoff医学博士领导。
Prosperity Bancshares Inc.是总部位于美国得克萨斯州休斯顿的银行控股公司，业务覆盖得克萨斯州及俄克拉荷马州中部。截至2019年12月31日，公司共运营285家分支机构，广泛分布在休斯顿、达拉斯-沃斯堡都会区及得州南部、东部、中部、西部等区域。
CORT vs PB — 直观对比
营收规模更大
PB
是对方的1.8倍
$202.1M
净利率更高
PB
高出19.6%
12.0%
两年增速更快
PB
近两年复合增速
17.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $202.1M | $367.6M |
| 净利润 | $24.3M | $116.3M |
| 毛利率 | 98.7% | — |
| 营业利润率 | 2.2% | — |
| 净利率 | 12.0% | 31.6% |
| 营收同比 | 11.1% | — |
| 净利润同比 | -21.0% | -10.7% |
| 每股收益（稀释后） | $0.20 | $1.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CORTPB
| Q1 26 | — | $367.6M | ||
| Q4 25 | $202.1M | $275.0M | ||
| Q3 25 | $207.6M | $273.4M | ||
| Q2 25 | $194.4M | $267.7M | ||
| Q1 25 | $157.2M | $265.4M | ||
| Q4 24 | $181.9M | $267.8M | ||
| Q3 24 | $182.5M | $261.7M | ||
| Q2 24 | $163.8M | $258.8M |
净利润CORTPB
| Q1 26 | — | $116.3M | ||
| Q4 25 | $24.3M | $139.9M | ||
| Q3 25 | $19.7M | $137.6M | ||
| Q2 25 | $35.1M | $135.2M | ||
| Q1 25 | $20.5M | $130.2M | ||
| Q4 24 | $30.7M | $130.1M | ||
| Q3 24 | $47.2M | $127.3M | ||
| Q2 24 | $35.5M | $111.6M |
毛利率CORTPB
| Q1 26 | — | — | ||
| Q4 25 | 98.7% | — | ||
| Q3 25 | 97.8% | — | ||
| Q2 25 | 98.2% | — | ||
| Q1 25 | 98.5% | — | ||
| Q4 24 | 98.4% | — | ||
| Q3 24 | 98.4% | — | ||
| Q2 24 | 98.5% | — |
营业利润率CORTPB
| Q1 26 | — | — | ||
| Q4 25 | 2.2% | 65.1% | ||
| Q3 25 | 4.9% | 64.4% | ||
| Q2 25 | 13.7% | 64.3% | ||
| Q1 25 | 2.2% | 62.7% | ||
| Q4 24 | 13.9% | 62.0% | ||
| Q3 24 | 25.5% | 62.1% | ||
| Q2 24 | 21.7% | 55.2% |
净利率CORTPB
| Q1 26 | — | 31.6% | ||
| Q4 25 | 12.0% | 50.9% | ||
| Q3 25 | 9.5% | 50.3% | ||
| Q2 25 | 18.1% | 50.5% | ||
| Q1 25 | 13.1% | 49.1% | ||
| Q4 24 | 16.9% | 48.6% | ||
| Q3 24 | 25.9% | 48.6% | ||
| Q2 24 | 21.7% | 43.1% |
每股收益（稀释后）CORTPB
| Q1 26 | — | $1.16 | ||
| Q4 25 | $0.20 | $1.48 | ||
| Q3 25 | $0.16 | $1.45 | ||
| Q2 25 | $0.29 | $1.42 | ||
| Q1 25 | $0.17 | $1.37 | ||
| Q4 24 | $0.25 | $1.36 | ||
| Q3 24 | $0.41 | $1.34 | ||
| Q2 24 | $0.32 | $1.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $372.2M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $647.8M | $8.2B |
| 总资产 | $836.7M | $43.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CORTPB
| Q1 26 | — | — | ||
| Q4 25 | $372.2M | — | ||
| Q3 25 | $421.7M | — | ||
| Q2 25 | $342.2M | — | ||
| Q1 25 | $322.8M | — | ||
| Q4 24 | $383.3M | — | ||
| Q3 24 | $380.3M | — | ||
| Q2 24 | $473.2M | — |
股东权益CORTPB
| Q1 26 | — | $8.2B | ||
| Q4 25 | $647.8M | $7.6B | ||
| Q3 25 | $631.9M | $7.7B | ||
| Q2 25 | $635.8M | $7.6B | ||
| Q1 25 | $683.3M | $7.5B | ||
| Q4 24 | $679.6M | $7.4B | ||
| Q3 24 | $638.8M | $7.4B | ||
| Q2 24 | $596.2M | $7.3B |
总资产CORTPB
| Q1 26 | — | $43.6B | ||
| Q4 25 | $836.7M | $38.5B | ||
| Q3 25 | $823.6M | $38.3B | ||
| Q2 25 | $801.7M | $38.4B | ||
| Q1 25 | $846.5M | $38.8B | ||
| Q4 24 | $840.6M | $39.6B | ||
| Q3 24 | $784.3M | $40.1B | ||
| Q2 24 | $714.6M | $39.8B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.4M | — |
| 自由现金流经营现金流 - 资本支出 | $38.4M | — |
| 自由现金流率自由现金流/营收 | 19.0% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | 1.58× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CORTPB
| Q1 26 | — | — | ||
| Q4 25 | $38.4M | $78.3M | ||
| Q3 25 | $54.5M | $194.8M | ||
| Q2 25 | $43.9M | $98.2M | ||
| Q1 25 | $5.1M | $178.2M | ||
| Q4 24 | $59.3M | $-205.8M | ||
| Q3 24 | $73.8M | $274.6M | ||
| Q2 24 | $41.2M | $216.5M |
自由现金流CORTPB
| Q1 26 | — | — | ||
| Q4 25 | $38.4M | $68.5M | ||
| Q3 25 | — | $185.7M | ||
| Q2 25 | $43.9M | $91.8M | ||
| Q1 25 | $5.0M | $171.1M | ||
| Q4 24 | $59.2M | $-210.7M | ||
| Q3 24 | $72.2M | $270.2M | ||
| Q2 24 | $40.8M | $211.8M |
自由现金流率CORTPB
| Q1 26 | — | — | ||
| Q4 25 | 19.0% | 24.9% | ||
| Q3 25 | — | 67.9% | ||
| Q2 25 | 22.6% | 34.3% | ||
| Q1 25 | 3.2% | 64.5% | ||
| Q4 24 | 32.5% | -78.7% | ||
| Q3 24 | 39.5% | 103.3% | ||
| Q2 24 | 24.9% | 81.8% |
资本支出强度CORTPB
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 3.6% | ||
| Q3 25 | 0.0% | 3.3% | ||
| Q2 25 | 0.0% | 2.4% | ||
| Q1 25 | 0.1% | 2.7% | ||
| Q4 24 | 0.1% | 1.8% | ||
| Q3 24 | 0.9% | 1.7% | ||
| Q2 24 | 0.3% | 1.8% |
现金转化率CORTPB
| Q1 26 | — | — | ||
| Q4 25 | 1.58× | 0.56× | ||
| Q3 25 | 2.77× | 1.42× | ||
| Q2 25 | 1.25× | 0.73× | ||
| Q1 25 | 0.25× | 1.37× | ||
| Q4 24 | 1.93× | -1.58× | ||
| Q3 24 | 1.56× | 2.16× | ||
| Q2 24 | 1.16× | 1.94× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CORT
暂无分部数据
PB
| Net Interest Income | $321.1M | 87% |
| Noninterest Income | $46.5M | 13% |
